In plain words

One trial in 30 overweight young adults found that 3 g of taurine a day for seven weeks lowered triglycerides, a type of blood fat. Another, in 20 people taking 1.5 g a day for eight weeks, found no change in blood fats. A study pooling many trials, which may include these two, found lower cholesterol and triglycerides.

The short answer

Two randomized trials measured blood fats and disagree. Zhang et al. (2003) gave 3 g daily for 7 weeks to 30 overweight or obese young adults; triglycerides and atherogenic index fell. Brøns et al. (2004) gave 1.5 g daily for 8 weeks to 20 people and found no effect on blood lipids. A 2024 meta-analysis of 1,024 people at 0.5 to 6 g daily found lower total and LDL cholesterol and triglycerides, HDL no different; it is a pooled estimate that may include the trials above, and the ledger has no duration for it. Certainty is low: both trials are small, short and unrepeated.

The 60-second version

Every study in the video is listed below, with its quote.

Watch on YouTube

Where the evidence sits

Blood fats fell

■ Randomized trial, Zhang et al., 2003 · 30 people · 7 weeks
◪ Pooled analysis, Tzang et al., 2024 · may overlap studies counted here · HDL no different
□ Review, Wu et al., 2020 · summarises other studies

No difference

■ Randomized trial, Brøns et al., 2004 · 20 people · 8 weeks

■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data

Evidence weight4444 / 100?

Who says what

SourceFindingDesignPeopleDose and lengthFunding and independence
Zhang et al., 2003Triglycerides and atherogenic index fellDouble-blind randomized trial30 overweight or obese young adults3 g a day for 7 weeksNot in ledger
Brøns et al., 2004No effect on blood lipidsRandomized, placebo-controlled201.5 g a day for 8 weeksNot in ledger
Tzang et al., 2024Total cholesterol, LDL, triglycerides lower; HDL no differentMeta-analysis of randomized trials1,0240.5 to 6 g a day; Not in ledger for lengthNot in ledger; pooled, may include the trials above
Wu et al., 2020Total and LDL cholesterol lowerReview summarising other studiesNot in ledger0.4 to 6 g a dayNot in ledger; reports others' studies
Zhang et al., 2003

Triglycerides and atherogenic index fell

Design
Double-blind randomized trial
People
30 overweight or obese young adults
Dose and length
3 g a day for 7 weeks
Funding
Not in ledger
Brøns et al., 2004

No effect on blood lipids

Design
Randomized, placebo-controlled
People
20
Dose and length
1.5 g a day for 8 weeks
Funding
Not in ledger
Tzang et al., 2024

Total cholesterol, LDL, triglycerides lower; HDL no different

Design
Meta-analysis of randomized trials
People
1,024
Dose and length
0.5 to 6 g a day; Not in ledger for length
Funding
Not in ledger; pooled, may include the trials above
Wu et al., 2020

Total and LDL cholesterol lower

Design
Review summarising other studies
People
Not in ledger
Dose and length
0.4 to 6 g a day
Funding
Not in ledger; reports others' studies

What did the two trials find?

Zhang and colleagues (2003) ran a double-blind randomized trial in 30 overweight or obese young adults without diabetes, who took 3 g of taurine a day for 7 weeks:

Taurine supplementation decreased TG and AI significantly.

Terms: TG is triglycerides, a blood fat; AI is the atherogenic index.

Brøns and colleagues (2004) compared 1.5 g a day with placebo for 8 weeks in 20 people:

There was no significant effect of taurine supplementation on blood lipid levels as well.

Do pooled studies and reviews show lower cholesterol?

Tzang and colleagues (2024) combined randomized trials covering 1,024 people at 0.5 to 6 g a day; the ledger has no duration for the lipid results. It is a pooled estimate that may include the two trials above, so it is not a third measurement. On total cholesterol it reported:

The pooled effect size showed a notable decrease in TC (WMD: −8.305 mg/dL, 95% CI: −13.771 to −2.929, p = 0.003)

Terms: TC is total cholesterol; WMD is the average difference between groups.

In the same 1,024 people at 0.5 to 6 g a day, a pooled estimate that may include the trials above, triglycerides and LDL cholesterol were lower than in control groups, and HDL cholesterol was no different; the ledger has no duration for these results.

Wu and colleagues (2020) reviewed other researchers' studies and report that 0.4 to 6 g a day lowered total and LDL cholesterol; the ledger has no n or duration for those studies, which may overlap with the trials above.

Why the sources disagree

Dose and length: Zhang's 30 volunteers took 3 g a day for 7 weeks, Brøns's 20 took 1.5 g a day for 8 weeks. Population: Zhang studied overweight or obese young adults without diabetes; the ledger has no description of who took part in the Brøns trial. Measures: Zhang names triglycerides and the atherogenic index, while the ledger holds the Brøns result only as blood lipid levels overall. Who is reporting: Tzang pooled trials that may include these two, and Wu reviewed other people's studies, so neither is an independent result. Funding: the ledger has none for any source.

What would settle it

A randomized trial comparing 1.5 g and 3 g of taurine a day with placebo for 12 weeks in several hundred adults, with triglycerides and total, LDL and HDL cholesterol as pre-registered outcomes reported against placebo. A matching result from a second, independent research group would raise the certainty from low to moderate.

How this page was made

The 4 sources are two randomized trials, a 2024 meta-analysis that may include those trials, and a 2020 review, drawn from a literature search of PubMed records on taurine. Animal, cell and disease-group studies were left out. Every claim was copied word for word from its source into the Longevity Circle ledger and checked against the original text, and a person approved each one. "Contested" means independent studies point in both directions; certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.

The ledger holds only 3 studies on this question.

Changelog: 23 Sep 2026, first version, 4 sources.